Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential
RecruitingOBSERVATIONAL
Enrollment
256
Participants
Timeline
Start Date
June 4, 2024
Primary Completion Date
June 4, 2026
Study Completion Date
June 4, 2026
Conditions
NSCLC
Trial Locations (1)
00144
RECRUITING
"IRCCS National Cancer Institute Regina Elena", Rome
All Listed Sponsors
lead
Regina Elena Cancer Institute
OTHER
NCT06807307 - Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential | Biotech Hunter | Biotech Hunter